Advertisement
Advertisement
LLY
Eli Lilly & Co.
1,217.08
USDSponsored
-3.20
-0.26%
Aug 13, 12:45 UTC -4
Open
LLY Earnings Reports
Positive Surprise Ratio
LLY beat 30 of 42 last estimates.
71%
Next Report
Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.38B
/$9.80
Implied change from Q2 26 (Revenue/ EPS)
-2.59%
/+16.95%
Implied change from Q3 25 (Revenue/ EPS)
+27.15%
/+39.60%
Eli Lilly & Co. earnings per share and revenue
On Aug 05, 2026, LLY reported earnings of 8.38 USD per share (EPS) for Q2 26, beating the estimate of 6.06 USD, resulting in a 38.14% surprise. Revenue reached 22.97 billion, compared to an expected 20.93 billion, with a 9.75% difference. The market reacted with a +4.86% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 9.80 USD, with revenue projected to reach 22.38 billion USD, implying an increase of 16.95% EPS, and decrease of -2.59% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ABBVIE INC.
Report Date
Jul 31, 2026 For Q2 26
Estimate
$3.67
Actual
$3.65
Surprise
-0.71%
Merck & Co., Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.13
Surprise
+52.33%
Novo-Nordisk A/S
Report Date
Aug 04, 2026 For Q2 26
Estimate
$5.03
Actual
$4.75
Surprise
-5.65%
Pfizer Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$0.69
Actual
$0.77
Surprise
+11.37%
Sanofi - ADR
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.91
Actual
$2.09
Surprise
+8.91%
Innoviva, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.44
Actual
-$1.13
Surprise
-356.35%
FAQ
What were Eli Lilly & Co.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Eli Lilly & Co. reported EPS of $8.38, beating estimates by 38.14%, and revenue of $22.97B, 9.75% above expectations.
How did the market react to Eli Lilly & Co.'s Q2 2026 earnings?
The stock price moved up 4.86%, changed from $1.12K before the earnings release to $1.17K the day after.
When is Eli Lilly & Co. expected to report next?
The next earning report is scheduled for Oct 29, 2026.
What are the forecasts for Eli Lilly & Co.'s next earnings report?
Based on 10
analysts, Eli Lilly & Co. is expected to report EPS of $9.80 and revenue of $22.38B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement